tiprankstipranks
Black Diamond Therapeutics, Inc. (BDTX)
NASDAQ:BDTX
US Market
BDTX
Black Diamond Therapeutics
RESEARCH TOOLSreports
Want to see BDTX full AI Analyst Report?

Black Diamond Therapeutics (BDTX) Stock News & Sentiment

1,612 Followers
Analyst Reiterates Buy on Black Diamond Therapeutics, Citing Differentiated EGFR Inhibitor and Strong Cash Runway Through 2028
Premium
Ratings
Analyst Reiterates Buy on Black Diamond Therapeutics, Citing Differentiated EGFR Inhibitor and Strong Cash Runway Through 2028
14d ago
BDTX
BDTX Upcoming Earnings Report: What to Expect?
Premium
Pre-Earnings
BDTX Upcoming Earnings Report: What to Expect?
2M ago
BDTX
Black Diamond Advances Silevertinib Combo Into Phase 2 for Hard‑to‑Treat Brain Cancer
Premium
Company Announcements
Black Diamond Advances Silevertinib Combo Into Phase 2 for Hard‑to‑Treat Brain Cancer
4M ago
BDTX
3 Low P/E Ratio Stocks Poised to Surge Over 100% in 2026
Premium
Market News
3 Low P/E Ratio Stocks Poised to Surge Over 100% in 2026
5M ago
BDTX
BTBT
Promising Phase 2 Trial Results and Strategic Partnerships Support Buy Rating for Black Diamond Therapeutics
Premium
Ratings
Promising Phase 2 Trial Results and Strategic Partnerships Support Buy Rating for Black Diamond Therapeutics
6M ago
BDTX
Promising Potential of Silevertinib in EGFR-Mutant NSCLC: Buy Rating Reiterated
Premium
Ratings
Promising Potential of Silevertinib in EGFR-Mutant NSCLC: Buy Rating Reiterated
6M ago
BDTX
Black Diamond Reports Promising Phase 2 Lung Cancer Data
Premium
Company Announcements
Black Diamond Reports Promising Phase 2 Lung Cancer Data
6M ago
8K
BDTX
More BDTX News >

BDTX News on the Web

BDTX and Brain Metastases: Why CNS Activity Could Matter in 2026
Zacks
Bullish
Black Diamond Stock: Weighing Catalysts vs. Concentration
Zacks
Bullish
BDTX: What Silevertinib Data Say About EGFR NSCLC Upside
Zacks
Bullish
Black Diamond Therapeutics price target raised to $14 from $13 at Wedbush
TipRanks News
Neutral
Piper Sandler Sticks to Its Buy Rating for Black Diamond Therapeutics (BDTX)
TipRanks News
Neutral
Stifel Nicolaus Keeps Their Buy Rating on Black Diamond Therapeutics (BDTX)
TipRanks News
Neutral
Black Diamond Therapeutics (BDTX) Receives a Buy from TD Cowen
TipRanks News
Bullish
Black Diamond Therapeutics reports Q4 EPS (27c), consensus (17c)
TipRanks News
Bullish

News Score - Last 7 Days

Not enough data to generate a sentiment score
BDTX
Sector Average
Media Buzz
This Week1 articles
Weekly Average1 articles
News Sentiment
Currently, no data available
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is BDTX’s Media Buzz Sentiment?
1 articles about BDTX were published this week. In an average week, 1 articles are published.
    What is BDTX’s weekly average amount of articles?
    In an average week, 1 articles about BDTX are published.
      What is BDTX’s News Sentiment?
      Currently, no data Available
      Healthcare Stocks that are Trending in the News
      GOSSGossamer Bio
      RLAYRelay Therapeutics
      IMVTImmunovant
      ROIVRoivant Sciences
      PROKProKidney
      Showing the stocks with the most bullish news sentiment over the past week